WO2025202996 - USE OF DNA-PK INHIBITOR IN PREPARATION OF A DRUG FOR USE IN THE TREATMENT OF TUMORS
National phase entry is expected:
Publication Number
WO/2025/202996
Publication Date
02.10.2025
International Application No.
PCT/IB2025/053309
International Filing Date
28.03.2025
Title **
[English]
USE OF DNA-PK INHIBITOR IN PREPARATION OF A DRUG FOR USE IN THE TREATMENT OF TUMORS
[French]
UTILISATION D'UN INHIBITEUR D'ADN-PK DANS LA PRÉPARATION D'UN MÉDICAMENT DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE TUMEURS
Applicants **
KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD.
Inventors
WEI, Yonggang
SUN, Yi
YE, Fei
LIU, Rui
Priority Data
202410376380.2
29.03.2024
CN
202411367638.9
29.09.2024
CN
202411380419.4
30.09.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2637 | |
| EPO | Filing, Examination, Granting | 15702 | |
| Japan | Filing, Examination, Granting | 2606 | |
| South Korea | Filing, Examination, Granting | 2980 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
30,465
Contact Us
Abstract[English]
The present invention provides the use of a DNA-PK inhibitor as an active ingredient in the preparation of a drug for use in the treatment of a tumor.[French]
La présente invention concerne l'utilisation d'un inhibiteur d'ADN-PK en tant que principe actif dans la préparation d'un médicament destiné à être utilisé dans le traitement d'une tumeur.